Frontlight ResearchEarly access
Trial site
Clinique de la Mémoire de l'Outaouais
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Mild cognitive impairment1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Active, not recruiting2 trials
- Terminated2 trials
- Completed1 trial
- Lead sponsor
- Biogen3 trials
- Eli Lilly and Company2 trials
Running trials
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Closed trials
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Completed
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026